Newly approved drug is effective in patients with prostate cancer

Apalutamide significantly delayed the onset of symptoms, metastasis or death in Phase III clinical trial

By Amanda Gibbs March 27, 2018 Portland, Oregon

Downloads

Julie Graff, M.D., (left) meets with David Seidl, (center) and his wife, Linda. Seidl was diagnosed with prostate cancer in 2013 and has been participating in a Phase III clinical trial. (Photo by Michael Moody)

Prostate cancer clinical trial

David Seidl, (left) and his wife, Linda, (center) meet with Dr. Julie Graff, during a recent appointment. Seidl was diagnosed with prostate cancer in 2013 and has been participating in a Phase III clinical trial. (Photo by Michael Moody)

Prostate cancer clinical trial